Global lung oncology branch trial 3 (GLOB3): Final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

  • E. H. Tan*
  • , J. Rolski
  • , T. Grodzki
  • , C. P. Schneider
  • , U. Gatzemeier
  • , P. Zatloukal
  • , E. Aitini
  • , G. Carteni
  • , H. Riska
  • , Y. H. Tsai
  • , R. Abratt
    • *此作品的通信作者

研究成果: 期刊稿件 › 文章 › 同行評審

59 引文 斯高帕斯（Scopus）

指紋

深入研究「Global lung oncology branch trial 3 (GLOB3): Final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer」主題。共同形成了獨特的指紋。
排序方式

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science